Is Surgepays Stock a Good Investment?
Surgepays Investment Advice | SURG |
- Examine Surgepays' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Surgepays' leadership team and their track record. Good management can help Surgepays navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Wireless Telecommunication Services space and any emerging trends that could impact Surgepays' business and its evolving consumer preferences.
- Compare Surgepays' performance and market position to its competitors. Analyze how Surgepays is positioned in terms of product offerings, innovation, and market share.
- Check if Surgepays pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Surgepays' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Surgepays stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Surgepays is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Unstable | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Examine Surgepays Stock
Researching Surgepays' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 30.0% of the company outstanding shares are owned by corporate insiders. The book value of Surgepays was at this time reported as 1.96. The company had not issued any dividends in recent years. Surgepays had 1:50 split on the 2nd of November 2021.
To determine if Surgepays is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Surgepays' research are outlined below:
Surgepays generated a negative expected return over the last 90 days | |
Surgepays has high historical volatility and very poor performance | |
About 30.0% of the company outstanding shares are owned by corporate insiders | |
Latest headline from news.google.com: SurgePays to Release Quarterly Earnings on Monday - Defense World |
Surgepays Quarterly Cash And Short Term Investments |
|
Surgepays uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Surgepays. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Surgepays' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
4th of April 2024 Upcoming Quarterly Report | View | |
31st of December 2023 Next Fiscal Quarter End | View |
Earnings surprises can significantly impact Surgepays' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Surgepays' investors have experienced.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2015-06-30 | 2015-06-30 | 0.04 | 0.05 | 0.01 | 25 | ||
2014-12-31 | 2014-12-31 | 0.02 | 0.03 | 0.01 | 50 | ||
2014-09-30 | 2014-09-30 | 0.02 | 0.03 | 0.01 | 50 | ||
2015-03-31 | 2015-03-31 | 0.02 | 0.04 | 0.02 | 100 | ||
2022-05-16 | 2022-03-31 | -0.04 | -0.1 | -0.06 | 150 | ||
2022-08-11 | 2022-06-30 | 0.01 | -0.07 | -0.08 | 800 | ||
2024-03-12 | 2023-12-31 | 0.41 | 0.2 | -0.21 | 51 | ||
2023-11-14 | 2023-09-30 | 0.28 | 0.49 | 0.21 | 75 |
Surgepays Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Surgepays target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Surgepays' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
2 | Buy |
Most Surgepays analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Surgepays stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Surgepays, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationSurgepays Target Price Projection
Surgepays' current and average target prices are 3.83 and 13.00, respectively. The current price of Surgepays is the price at which Surgepays is currently trading. On the other hand, Surgepays' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Surgepays Target Price
Surgepays Analyst Ratings
Surgepays' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Surgepays stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Surgepays' financials, market performance, and future outlook by experienced professionals. Surgepays' historical ratings below, therefore, can serve as a valuable tool for investors.Know Surgepays' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Surgepays is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Surgepays backward and forwards among themselves. Surgepays' institutional investor refers to the entity that pools money to purchase Surgepays' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | State Street Corporation | 2023-12-31 | 30.4 K | Blair William & Co | 2023-12-31 | 26.3 K | Gsa Capital Partners Llp | 2023-12-31 | 21 K | Jump Financial, Llc | 2023-12-31 | 16.5 K | Victory Capital Management Inc. | 2023-12-31 | 16.4 K | Cubist Systematic Strategies, Llc | 2023-12-31 | 16.1 K | Fny Investment Advisers, Llc | 2023-12-31 | 14.8 K | Advisor Group Holdings, Inc. | 2023-12-31 | 13 K | Ausdal Financial Partners Inc | 2023-12-31 | 12.7 K | Vanguard Group Inc | 2023-12-31 | 467.2 K | Myda Advisors Llc | 2023-12-31 | 136.5 K |
Surgepays' market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 73.85 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Surgepays's market, we take the total number of its shares issued and multiply it by Surgepays's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Market Cap |
|
Surgepays' profitablity analysis
Surgepays' profitability indicators refer to fundamental financial ratios that showcase Surgepays' ability to generate income relative to its revenue or operating costs. If, let's say, Surgepays is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Surgepays' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Surgepays' profitability requires more research than a typical breakdown of Surgepays' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.55 | 0.57 | |
Return On Capital Employed | 0.64 | 0.67 | |
Return On Assets | 0.49 | 0.51 | |
Return On Equity | 0.73 | 0.69 |
Determining Surgepays' profitability involves analyzing its financial statements and using various financial metrics to determine if Surgepays is a good buy. For example, gross profit margin measures Surgepays' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Surgepays' profitability and make more informed investment decisions.
The data published in Surgepays' official financial statements usually reflect Surgepays' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Surgepays. For example, before you start analyzing numbers published by Surgepays accountants, it's critical to develop an understanding of what Surgepays' liquidity, profitability, and earnings quality are in the context of the Wireless Telecommunication Services space in which it operates.
Please note, the presentation of Surgepays' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Surgepays' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Surgepays' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Surgepays. Please utilize our Beneish M Score to check the likelihood of Surgepays' management manipulating its earnings.
Evaluate Surgepays' management efficiency
Surgepays has return on total asset (ROA) of 0.3106 % which means that it generated a profit of $0.3106 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 1.2317 %, meaning that it created $1.2317 on every $100 dollars invested by stockholders. Surgepays' management efficiency ratios could be used to measure how well Surgepays manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Surgepays' Return On Assets are most likely to increase significantly in the upcoming years. At this time, Surgepays' Non Current Assets Total are most likely to increase significantly in the upcoming years. The Surgepays' current Other Assets is estimated to increase to about 213.5 K, while Non Currrent Assets Other are forecasted to increase to (512.5 K).Last Reported | Projected for Next Year | ||
Book Value Per Share | 1.98 | 3.96 | |
Net Current Asset Value | 0.00 | 0.00 | |
Tangible Asset Value | 0.00 | 0.00 | |
Tangible Book Value Per Share | 1.69 | 3.06 | |
Enterprise Value Over EBITDA | 4.14 | 4.35 | |
Price Book Value Ratio | 3.26 | 3.42 | |
Enterprise Value Multiple | 4.14 | 4.35 | |
Price Fair Value | 3.26 | 3.42 | |
Enterprise Value | 82.8 M | 86.9 M |
The analysis of Surgepays' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Surgepays' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Surgepays Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 1.471 |
Basic technical analysis of Surgepays Stock
As of the 12th of May 2024, Surgepays has the Risk Adjusted Performance of (0.08), variance of 41.09, and Coefficient Of Variation of (686.10). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Surgepays, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for Surgepays, which can be compared to its competition. Please validate Surgepays risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Surgepays is priced more or less accurately, providing market reflects its prevalent price of 3.83 per share. Given that Surgepays has information ratio of (0.16), we advise you to double-check Surgepays's current market performance to make sure the company can sustain itself at a future point.Surgepays' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Surgepays insiders, such as employees or executives, is commonly permitted as long as it does not rely on Surgepays' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Surgepays insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
John Mott over three weeks ago Acquisition by John Mott of 8750 shares of Surgepays at 0.0871 subject to Rule 16b-3 | ||
Kevin Cox over three weeks ago Acquisition by Kevin Cox of 4900 shares of Surgepays at 4. subject to Rule 16b-3 | ||
Anthony Nuzzo over a month ago Disposition of 72000 shares by Anthony Nuzzo of Surgepays subject to Rule 16b-3 | ||
May David Allen over a month ago Acquisition by May David Allen of 38390 shares of Surgepays at 2.06 subject to Rule 16b-3 | ||
Kevin Cox over two months ago Discretionary transaction by Kevin Cox of tradable shares of Surgepays subject to Rule 16b-3 | ||
May David Allen over six months ago Acquisition by May David Allen of 15000 shares of Surgepays subject to Rule 16b-3 | ||
Kevin Cox over six months ago Purchase by Kevin Cox of 5200 shares of Surgepays | ||
David Keys over six months ago Acquisition by David Keys of 32000 shares of Surgepays subject to Rule 16b-3 |
Understand Surgepays' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Surgepays' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
Risk Adjusted Performance | (0.08) | |||
Market Risk Adjusted Performance | (0.41) | |||
Mean Deviation | 4.74 | |||
Coefficient Of Variation | (686.10) | |||
Standard Deviation | 6.41 | |||
Variance | 41.09 | |||
Information Ratio | (0.16) | |||
Jensen Alpha | (1.11) | |||
Total Risk Alpha | (1.71) | |||
Treynor Ratio | (0.42) | |||
Maximum Drawdown | 39.14 | |||
Value At Risk | (9.89) | |||
Potential Upside | 8.59 | |||
Skewness | (1.03) | |||
Kurtosis | 3.9 |
Risk Adjusted Performance | (0.08) | |||
Market Risk Adjusted Performance | (0.41) | |||
Mean Deviation | 4.74 | |||
Coefficient Of Variation | (686.10) | |||
Standard Deviation | 6.41 | |||
Variance | 41.09 | |||
Information Ratio | (0.16) | |||
Jensen Alpha | (1.11) | |||
Total Risk Alpha | (1.71) | |||
Treynor Ratio | (0.42) | |||
Maximum Drawdown | 39.14 | |||
Value At Risk | (9.89) | |||
Potential Upside | 8.59 | |||
Skewness | (1.03) | |||
Kurtosis | 3.9 |
Consider Surgepays' intraday indicators
Surgepays intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Surgepays stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Surgepays Corporate Filings
F4 | 3rd of May 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 22nd of April 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10K | 12th of March 2024 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
5th of February 2024 Other Reports | ViewVerify |
Surgepays Stock media impact
Far too much social signal, news, headlines, and media speculation about Surgepays that are available to investors today. That information is available publicly through Surgepays media outlets and privately through word of mouth or via Surgepays internal channels. However, regardless of the origin, that massive amount of Surgepays data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Surgepays news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Surgepays relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Surgepays' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Surgepays alpha.
Surgepays Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Surgepays can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Surgepays without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
All Next | Launch Module |
Surgepays Corporate Management
Elected by the shareholders, the Surgepays' board of directors comprises two types of representatives: Surgepays inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Surgepays. The board's role is to monitor Surgepays' management team and ensure that shareholders' interests are well served. Surgepays' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Surgepays' outside directors are responsible for providing unbiased perspectives on the board's policies.
Carter Matzinger | Chief LogicsIQ | Profile | |
CPA CIA | CFO COO | Profile | |
John Mott | Chief Officer | Profile | |
Brian CFA | Managing MZ | Profile | |
MBA JD | Secretary Services | Profile | |
Jeremy Gies | I Fintech | Profile |
How to buy Surgepays Stock?
To provide specific investment advice or recommendations on Surgepays stock, we recommend investors consider the following general factors when evaluating Surgepays. This will help you to make an informed decision on whether to include Surgepays in one of your diversified portfolios:- Examine Surgepays' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Surgepays' leadership team and their track record. Good management can help Surgepays navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Wireless Telecommunication Services space and any emerging trends that could impact Surgepays' business and its evolving consumer preferences.
- Compare Surgepays' performance and market position to its competitors. Analyze how Surgepays is positioned in terms of product offerings, innovation, and market share.
- Check if Surgepays pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Surgepays' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Surgepays stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Surgepays is a good investment.
Already Invested in Surgepays?
The danger of trading Surgepays is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Surgepays is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Surgepays. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Surgepays is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Surgepays is a strong investment it is important to analyze Surgepays' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Surgepays' future performance. For an informed investment choice regarding Surgepays Stock, refer to the following important reports: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for Surgepays Stock analysis
When running Surgepays' price analysis, check to measure Surgepays' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgepays is operating at the current time. Most of Surgepays' value examination focuses on studying past and present price action to predict the probability of Surgepays' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgepays' price. Additionally, you may evaluate how the addition of Surgepays to your portfolios can decrease your overall portfolio volatility.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Transaction History View history of all your transactions and understand their impact on performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |
Is Surgepays' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgepays. If investors know Surgepays will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgepays listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.17) | Earnings Share 1.38 | Revenue Per Share 9.618 | Quarterly Revenue Growth (0.11) | Return On Assets 0.3106 |
The market value of Surgepays is measured differently than its book value, which is the value of Surgepays that is recorded on the company's balance sheet. Investors also form their own opinion of Surgepays' value that differs from its market value or its book value, called intrinsic value, which is Surgepays' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgepays' market value can be influenced by many factors that don't directly affect Surgepays' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Surgepays' value and its price, as these two are different measures arrived at by various means. Investors typically determine if Surgepays is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgepays' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.